Actosmet 15mg/850mg Tablets, for Type 2 Diabetes Management & Glycemic Control - 56 Tablets
2-3 days · Free over 100,000 IQD
Medication Registration Required
Add this to your medications to purchase
Actosmet 15mg/850mg is a powerful combination medication designed to effectively manage Type 2 Diabetes Mellitus in adults. It combines two active ingredients, Pioglitazone and Metformin, to target different aspects of glucose control, particularly beneficial for overweight patients when diet and exercise alone are not enough. • Dual-Action Formula: Contains Pioglitazone (a thiazolidinedione) to improve insulin sensitivity and Metformin (a biguanide) to reduce glucose production by the liver and improve glucose uptake. • Comprehensive Glycemic Control: Works synergistically to lower blood sugar levels, helping to achieve better long-term glycemic management. • Targeted for Type 2 Diabetes: Specifically indicated for adults with Type 2 Diabetes, often used when monotherapy with either ingredient is insufficient. • Adjunct to Lifestyle Changes: Best used in conjunction with a healthy diet and regular exercise to maximize its therapeutic benefits.
To ensure optimal effectiveness and minimize side effects, follow these usage instructions carefully: • Take Actosmet 15mg/850mg orally, usually once or twice daily. • It is recommended to take the tablets with meals to help reduce potential gastrointestinal side effects. • Swallow the tablets whole with water; do not crush, chew, or break them. • Regularly monitor your blood glucose levels as directed by your physician. • Do not discontinue this medication without consulting your doctor, and strictly adhere to any dietary and exercise recommendations provided. Always use this medication exactly as prescribed by your doctor or as advised by your pharmacist.
- Active Ingredients
- metformin, pioglitazone
- Scientific Name
- Metformin + Pioglitazone
- Manufacturer
- hikma
- Packing
- 56 tablets
- Country of Origin
- Jordan
- Certifications
- fda approved
Actosmet should be used with caution and under medical supervision. It is contraindicated in patients with heart failure (NYHA Class III or IV), severe renal impairment, or known hypersensitivity to its components. Pioglitazone may increase the risk of heart failure and bladder cancer. Metformin carries a risk of lactic acidosis, especially in patients with kidney problems, severe infection, or dehydration. Report any unusual muscle pain, difficulty breathing, or severe fatigue to your doctor immediately. Not recommended during pregnancy or breastfeeding without consulting a healthcare professional.
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.
Frequently Asked Questions
Reviews
No reviews yet